Toshifusa Nakajima Selected Research

Adjuvant Chemotherapy

4/2016	Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial).
9/2014	What make differences in the outcome of adjuvant treatments for resected gastric cancer?
10/2013	Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1.
11/2011	Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.
8/2011	Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2.
11/2007	Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
1/2004	Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
6/2003	Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
12/2002	[Progress in postoperative adjuvant chemotherapy in gastric cancer].
1/2002	Determining prognostic factors for gastric cancer using the regression tree method.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshifusa Nakajima Research Topics

Disease

18	Stomach Neoplasms (Stomach Cancer) 05/2018 - 01/2002
11	Neoplasms (Cancer) 01/2017 - 01/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 11/2013
4	Neutropenia 01/2015 - 01/2004
3	Rectal Neoplasms (Rectal Cancer) 01/2019 - 01/2015
3	Carcinoma (Carcinomatosis) 01/2019 - 06/2013
2	Diarrhea 05/2004 - 01/2004
1	Vomiting 05/2018
1	Adenoma (Adenomas) 06/2013
1	Cicatrix (Scar) 06/2013
1	Adenocarcinoma 06/2013
1	Heart Diseases (Heart Disease) 10/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2012
1	Overweight 12/2009
1	Neoplasm Metastasis (Metastasis) 05/2009
1	Lymphatic Metastasis 05/2004
1	Nausea 01/2004
1	Fatigue 01/2004
1	Leukopenia 01/2004
1	Anorexia 01/2004
1	Stomatitis 01/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2002

Drug/Important Bio-Agent (IBA)

6	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 06/2003
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 09/2014
5	Cisplatin (Platino)FDA LinkGeneric 05/2018 - 05/2004
3	Cetuximab (Erbitux)FDA Link 01/2017 - 01/2016
3	Pharmaceutical PreparationsIBA 04/2016 - 10/2012
2	Trastuzumab (Herceptin)FDA Link 05/2018 - 01/2018
2	S-1 plus cisplatinIBA 05/2018 - 02/2014
2	Leucovorin (Folinic Acid)FDA Link 09/2014 - 11/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2013 - 05/2004
1	Biological ProductsIBA 01/2016
1	LigandsIBA 01/2016
1	EpiregulinIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AmphiregulinIBA 01/2016
1	Capecitabine (Xeloda)FDA Link 09/2014
1	Drug CombinationsIBA 09/2014
1	Epirubicin (Ellence)FDA LinkGeneric 09/2014
1	PlatinumIBA 02/2014
1	Platinum Compounds (Compounds, Platinum)IBA 02/2014
1	Docetaxel (Taxotere)FDA Link 02/2014
1	Bevacizumab (Avastin)FDA Link 11/2013
1	titanium silicide (TS-1)IBA 10/2013
1	Gemcitabine FDA Link 05/2012
1	S 1 (combination)IBA 05/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2011
1	Pepsinogen A (Pepsinogen)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	tegafur-gimeracil-oteracilIBA 01/2004
1	BilirubinIBA 01/2004
1	PotassiumIBA 01/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2003
1	Asialoglycoprotein ReceptorIBA 11/2002

Therapy/Procedure

10	Adjuvant Chemotherapy 04/2016 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2017 - 06/2003
6	Gastrectomy 06/2013 - 01/2004
5	Lymph Node Excision (Lymph Node Dissection) 11/2011 - 01/2002
4	Chemoradiotherapy 01/2019 - 09/2014
4	Therapeutics 10/2013 - 05/2004
1	FPEPIR regimen 09/2014
1	Radiotherapy 09/2014
1	Operative Surgical Procedures 12/2009